Total Payments
$20,673
2024 Payments
$18,632
Companies
13
Transactions
67
Medicare Patients
1,367
Medicare Billing
$263,019
Payment Breakdown by Category
Consulting$8,000 (38.7%)
Other$4,913 (23.8%)
Food & Beverage$4,887 (23.6%)
Travel$2,873 (13.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,000 | 4 | 38.7% |
| Honoraria | $4,913 | 5 | 23.8% |
| Food and Beverage | $4,887 | 53 | 23.6% |
| Travel and Lodging | $2,873 | 5 | 13.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ocular Therapeutix, Inc. | $6,594 | 9 | $0 (2024) |
| Alimera Sciences, Inc. | $4,327 | 12 | $0 (2024) |
| Genentech USA, Inc. | $3,198 | 6 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $2,307 | 6 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $2,011 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $909.70 | 10 | $0 (2024) |
| Alcon Vision LLC | $417.55 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $346.97 | 5 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $221.64 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $104.58 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,632 | 50 | Ocular Therapeutix, Inc. ($6,594) |
| 2023 | $1,680 | 13 | Alimera Sciences, Inc. ($1,206) |
| 2022 | $238.96 | 3 | Genentech USA, Inc. ($134.38) |
| 2021 | $122.16 | 1 | Regeneron Healthcare Solutions, Inc. ($122.16) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Honoraria | Cash or cash equivalent | $1,275.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $135.01 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Ophthalmology | ||||||
| 11/16/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $224.94 | General |
| Category: Ophthalmology | ||||||
| 11/16/2024 | Alcon Vision LLC | — | Travel and Lodging | In-kind items and services | $192.61 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Ocular Therapeutix, Inc. | — | Travel and Lodging | In-kind items and services | $918.33 | General |
| 11/15/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $37.00 | General |
| 11/15/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $28.00 | General |
| 11/14/2024 | Ocular Therapeutix, Inc. | — | Food and Beverage | In-kind items and services | $95.00 | General |
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $945.74 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $306.83 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $215.50 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/21/2024 | Ocular Therapeutix, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,480.00 | General |
| 10/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $39.53 | General |
| Category: EYE CARE | ||||||
| 10/19/2024 | Apellis Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $1,298.25 | General |
| 10/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $200.43 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/19/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $189.82 | General |
| Category: Ophthalmology | ||||||
| 10/19/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $151.92 | General |
| Category: Ophthalmology | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,820.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $179.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/03/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $126.95 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 661 | 815 | $309,721 | $141,482 |
| 2022 | 16 | 578 | 693 | $307,735 | $110,949 |
| 2021 | 6 | 128 | 135 | $41,800 | $10,588 |
Total Patients
1,367
Total Services
1,643
Medicare Billing
$263,019
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 48 | 126 | $158,650 | $86,436 | 54.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 78 | 96 | $49,467 | $9,366 | 18.9% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 16 | 16 | $18,903 | $7,431 | 39.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 72 | 76 | $12,335 | $7,415 | 60.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 18 | 18 | $18,990 | $4,940 | 26.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 42 | 42 | $7,994 | $4,357 | 54.5% |
| 92134 | Imaging of retina | Office | 2023 | 124 | 145 | $7,508 | $4,310 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 35 | $6,387 | $3,538 | 55.4% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 11 | 11 | $7,347 | $3,150 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 41 | $4,364 | $3,003 | 68.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,076 | $2,321 | 75.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 19 | 31 | $4,010 | $1,710 | 42.6% |
| 92134 | Imaging of retina | Facility | 2023 | 52 | 60 | $5,411 | $1,119 | 20.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 19 | 23 | $1,334 | $826.55 | 62.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 36 | 39 | $1,019 | $749.87 | 73.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Facility | 2023 | 13 | 13 | $1,542 | $439.40 | 28.5% |
| 92250 | Photography of the retina | Facility | 2023 | 12 | 12 | $1,152 | $204.00 | 17.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 14 | 14 | $232.54 | $165.10 | 71.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 31 | 90 | $137,732 | $64,962 | 47.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 103 | 118 | $20,973 | $11,886 | 56.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 53 | 68 | $48,378 | $6,815 | 14.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 33 | 33 | $28,451 | $5,804 | 20.4% |
| 67040 | Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser | Facility | 2022 | 14 | 14 | $14,744 | $2,650 | 18.0% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 21 | 21 | $11,760 | $2,393 | 20.3% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 15 | 15 | $9,300 | $2,257 | 24.3% |
About Dr. Samuel Minaker, M.D
Dr. Samuel Minaker, M.D is a Retina Specialist healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2021. The National Provider Identifier (NPI) number assigned to this provider is 1174194955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Minaker, M.D has received a total of $20,673 in payments from pharmaceutical and medical device companies, with $18,632 received in 2024. These payments were reported across 67 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($8,000).
As a Medicare-enrolled provider, Minaker has provided services to 1,367 Medicare beneficiaries, totaling 1,643 services with total Medicare billing of $263,019. Data is available for 3 years (2021–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology, Retina Specialist
- Location Tyler, TX
- Active Since 07/02/2021
- Last Updated 10/01/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1174194955
Products in Payments
- ILUVIEN (Drug) $3,950
- Vabysmo (Drug) $3,064
- EYP-1901 (Drug) $2,284
- Syfovre (Drug) $712.34
- Izervay (Drug) $614.56
- YUTIQ (Drug) $400.29
- DEXTENZA (Drug) $335.84
- EYLEA HD (Biological) $224.30
- PURIFIED CORTROPHIN GEL (Drug) $221.64
- EYLEA (Biological) $221.59
- VABYSMO (Drug) $134.38
- XIPERE (Drug) $104.58
- OZURDEX (Drug) $102.10
- Cimerli (Biological) $33.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.